Principal Securities’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$263K Buy
1,172
+177
+18% +$44.1K ﹤0.01% 1268
2025
Q4
$240K Buy
995
+136
+16% +$34.8K ﹤0.01% 1241
2025
Q3
$235K Sell
859
-257
-23% -$70.2K ﹤0.01% 1221
2025
Q2
$288K Buy
1,116
+734
+192% +$175K 0.01% 1079
2025
Q1
$87.4K Hold
382
﹤0.01% 1493
2024
Q4
$87.4K Buy
382
+29
+8% +$6.98K ﹤0.01% 1491
2024
Q3
$86.2K Buy
353
+43
+14% +$9.61K ﹤0.01% 1468
2024
Q2
$59.3K Buy
310
+26
+9% +$5.28K ﹤0.01% 1546
2024
Q1
$56.2K Sell
284
-3
-1% -$550 ﹤0.01% 1518
2023
Q4
$49.4K Buy
+287
New +$44.1K ﹤0.01% 1494

Other funds holding RMD

Principal Securities's RMD Position: Q1 2026 in Review

Principal Securities increased its ResMed (RMD) stake by 18% in Q1 2026, buying an estimated $44.1K and bringing the position to 1,172 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #1268.

Principal Securities first reported a position in RMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $288K in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Principal Securities held 1,172 shares of ResMed worth $263K as of Q1 2026.
  • Principal Securities bought 177 ResMed shares in Q1 2026, an estimated $44.1K.
  • ResMed made up ﹤0.01% of Principal Securities's portfolio in Q1 2026, its #1268 holding.
  • Principal Securities first reported a position in ResMed in Q4 2023 and has held it in 10 quarters since.
  • Principal Securities's ResMed position peaked at $288K in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.